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Mutations in cardiac myosin-binding protein-C (cMyBP-C), are the most com-
mon cause of Hypertrophic CardioMyopathy (HCM). The E258K-cMyBP-C
is a penetrant missense mutation with poorly understood molecular mecha-
nisms. Mechanics and kinetics of contraction as well the energy cost of ten-
sion generation were investigated using left ventricular (LV) and atrial
tissue from E258K HCM patients and donor hearts. Kinetics of tension gener-
ation and relaxation were measured in LV and atrial myofibrils while ATPase
and isometric active tension were simultaneously measured in permeabilized
LV and atrial strips. The rate of tension generation following maximal
Ca2þ-activation was faster in both LV and atrial E258K myofibrils compared
to donors. The rate of isometric relaxation was also faster in E258K myofi-
brils, suggesting faster cross-bridge detachment and increased energy cost
of tension generation. Direct measurements in skinned LV and atrial strips
confirmed that tension cost was higher in E258K preparations compared to
controls. To check whether cardiomyocyte disarray, typical of HCM hearts,
may have contributed to artificially increase the tension cost measured in
the HCM preparations, the strips used for mechanical investigations were clar-
ified, immunostained and imaged at mesoscale level. An advanced tissue
clearing method in combination with two-photon microscopy was employed
to reconstruct the 3D image of the strips at sub-micrometer spatial resolution.
A 3D cytoarchitecture analysis tool based on 3D Fourier Transform was
developed and applied to determine cardiomyocyte orientation across and
along the strips. Both global and local statistics of spatial disarray were
derived and correlated to mechanical and energetic data. The results did not
highlight structural differences between donor and HCM strips strengthening
the conclusion that the E258K mutation primarily alters apparent cross-bridge
kinetics and impairs sarcomere energetics. Acknowledgement: H2020EU
SILICOFCM grant agreement 777204.
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Head-to-tail association of coiled-coil tropomyosin dimers produce four-helix
bundle ‘‘overlapping domains’’ connecting the dimers together. This polymer-
ization process yields elongated super-helical cables that interact continuously
with the surface of the actin filament. While considerable computationally
generated information is available on the local and global interactions between
isolated (unpolymerized) tropomyosin dimers and F-actin (Li et al., 2011), lit-
tle is known about the influence of the overlapping domain on the structural-
mechanics of tropomyosin and hence corresponding tropomyosin behavior on
actin filaments. In an effort to elucidate localized overlapping domain - actin
interaction and ensuing regulatory translocation across actin, we compared
molecular dynamics simulations of models of single dimeric tropomyosin mol-
ecules (as in Li et al., 2010) with new models of tropomyosin cables. The sim-
ulations of tropomyosin cables were performed with the tropomyosin polymer
constrained to a native super-helical configuration as if linked to a ghost
F-actin filament at a radius of 39 Å, thereby maximizing native flexural
and twisting motions without being dampened by interaction with F-actin.
We have recently shown that torsional motions and sequence-dependent
twisting of tropomyosin is initiated and propagated from aspartate-137 and
surrounding amino acids and is critical for tropomyosin function (Lehman et
al., 2018). We now have shown that the sequence-specific twisting pattern
of tropomyosin is virtually unaffected by the additional presence of the over-
lapping domain, while the flexural motions of tropomyosin are dampened as
expected. In addition, related MD shows that torsional (and flexural) mobility
of the overlapping domain itself appears to be unaffected by the presence of
the remainder of the molecule. We conclude that the material properties oftropomyosin are dominated by its dimeric coiled-coil region and that the
main function of overlapping domain is to sponsor tropomyosin polymeriza-
tion and cable formation.
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Protein Kinase C-Mediated Cardiac Troponin I S43/45 Phosphorylation
Causes Contractile Dysfunction in Human Heart Failure and in Rodents
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Cardiac dysfunction is linked to increased protein kinase C (PKC) expression,
but the role of downstream myofilament phosphorylation is debated. The cur-
rent experiments evaluate the contribution of PKC-mediated cardiac troponin
I (cTnI) S43/45 phosphorylation (p-S43/45) to contractile dysfunction. West-
ern analysis showed increased cTnI p-S43 and PKC expression in failing hu-
man myocardium, and hearts from a rat pressure overload (PO) model.
Myocyte contractile dysfunction was also present in failing (F) versus non-
failing (NF) human myocytes, and in PO versus sham rat myocytes. Contrac-
tile function and cTnI p-S43 levels were partially restored in F human
myocytes after ventricular assist device support, and gene transfer of domi-
nant negative PKC-alpha. Based on these findings, transgenic mice were
generated with a range of cardiac-specific phospho-mimetic cTnI S43/45D
(SD) replacing endogenous cTnI, to directly test the contribution of p-S43/
45 to cardiac dysfunction and remodeling. In young adults (4 wks), high
(HE-), medium (ME-) and low (LE-) SD expression did not cause significant
changes in cardiac morphology/remodeling compared to non-transgenic (ntg)
littermates. By 8 wks, HE-SD mice developed increased heart weight/tibial
length ratio which continued to increase at 12 wks compared to LE-, ME-
SD and ntg mice. Echocardiography showed progressive increases in left ven-
tricular systolic dimension (LVDs) and decreases in ejection fraction between
8 and 12 wks in ME- and HE-SD mice (8 wks: ntg EF% = 54.9þ1.7, n=4,
ME-SD = 38þ1.3*, n=3; HE-SD = 27.1þ 5.9* n=3; 12 wks: ntg EF% =
52.8þ4.6, n=3; ME-SD = 35.1þ3.3*, n=5; HE-SD = 16.7þ6.2*, n=3;
*p<0.05 by ANOVA), and 95% of HE-SD mice died before 20 wks of
age. Taken together, the results show that chronic phosphorylation of cTnI
S43/45 is a significant contributor to progressive cardiac dysfunction and heart
failure.
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Very little is known about post-translational modifications (PTM) of myosin
heavy chain (MHC) in the human heart. Protein acetylation is a PTM, shown
of instrumental importance as a modification of histone proteins. More recently
it has been uncovered that the realm of lysine-acetylation extends beyond the
nucleus. Protein phosphorylation is a well-known PTM found on several sar-
comeric proteins in the heart and is crucial for fine-tuning myocardial contrac-
tility. To our knowledge, we were first to report alpha-MHC phosphorylation
in murine hearts. Given the emergent importance of the broader lysine-
acetylome and sarcomeric protein phosphorylation during heart failure, we
examined PTMs in human heart beta-MHC. Here, using bottom-up prote-
omics, we identified six high-confidence lysine acetylation sites (three each
in myosin-S1 and rod domains) and eight high-confidence phosphorylation
sites (six in myosin-S1 and two in myosin rod regions). Furthermore, the acet-
ylation and phosphorylation status of some of these sites changed in ischemic
failing (IF) and non-ischemic failing (NIF) hearts compared to donor non-
failing human hearts. Using label-free quantification, we found reduced acety-
lation of four lysine residues in IF and NIF human hearts. However, in IF
human hearts differential acetylation was apparent, with two lysine residues
in myosin-S1 exhibiting enhanced acetylation. Analysis of the phosphorylation
sites is currently in progress. Additionally, we identified a region in the
myosin-S1 ATP-binding pocket that exhibits both acetylated and phosphory-
lated residues, suggesting the importance of specific changes in the amino
acid architecture in this region. It will be of interest to determine: (i) the func-
tional role of these PTM sites; and (ii) whether altered acetylation of beta-
MHC aberrantly effects human heart function and in turn contributes to
